UPDATE : Friday, July 19, 2019
MedPacto passes tech assessment, seeks KOSDAQ listing this year by Jeong Sae-im 2019-07-19 17:01
Employees file suit against Galderma Korea by Kim Yun-mi 2019-07-19 15:41
‘Insurance benefits needed for Ibrance-fulvestrant combo treatment’ by Kim Yun-mi 2019-07-18 17:04
2 cancer immunotherapy makers face different situations in reimbursement talks by Kim Yun-mi 2019-07-18 16:01
Bridge Biotherapeutics licenses out IPF treatment candidate to Boehringer by Lee Han-soo 2019-07-18 15:58
GC Labcell releases pre-clinical trial results for NK cell treatment by Lee Han-soo 2019-07-18 14:22
Sanofi vaccinates Gwangju FINA Championships staffs against hepatitis A by Lee Han-soo 2019-07-18 10:49
CrystalGenomics’ US partner starts injecting leukemia treatment candidate by Lee Han-soo 2019-07-17 17:45
‘RIGHT Fund aims to use Korean innovation for global health equity’ by Lee Han-soo 2019-07-17 17:41
Korean, Japanese healthcare firms reaffirm ‘joint growth’ amid trade feud by Jeong Sae-im 2019-07-17 14:06
RIGHT Fund reveals 1st investment into public health projects in developing countries by Lee Han-soo 2019-07-17 14:03
'Biktarvy -- a pill a day to treat HIV' by Lee Han-soo 2019-07-17 10:09
Ono Pharma Korea names new CEO by Lee Han-soo 2019-07-16 11:24
Daewoong, Medytox differ in interpreting US trade agency’s order by Lee Han-soo 2019-07-15 17:44
Self-claimed Korea Otsuka employee causes stir on far-right website by Lee Han-soo 2019-07-15 15:57
China OKs Huonland's hyaluronic acid eye drop by Lee Han-soo 2019-07-15 13:57
Japanese pharma companies closely following 'Boycott Japan' campaign by Lee Han-soo 2019-07-12 17:07
Daewoong to co-promote Lundbeck Korea's Alzheimer's disease treatment by Lee Han-soo 2019-07-12 15:13
Regulator OKs Merck Korea's relapsing-remitting multiple sclerosis treatment by Lee Han-soo 2019-07-11 17:39
Humira permitted for nursing, pregnant patients by Kim Yun-mi 2019-07-11 16:41
Back to Top